
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Futura Medical Plc | FUM | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
11.30 | 10.50 | 11.30 | 10.25 | 11.175 |
Industry Sector |
---|
PHARMACEUTICALS & BIOTECHNOLOGY |
Top Posts |
---|
Posted at 15/4/2025 10:01 by bandflex 2024 full year UK and Euro revenue £47788702024 H1 UK and Euro revenue £2759280 So H2 revenue fell to £ 2019590 even though it was released in more euro countries. 2024 rest of world full year revenue £1,312,198 2024 H1 rest of world revenue £ 1,014,830 So 2024 H2 rest of world revenue cratered to £ 297368 US launched in 2024 H2 so no comparison for sales revenue only milestone payments. Sales have clearly fallen towards the end of 2024 and have gotten worse in all markets in 2025, but FUM will hide the figures until the 2025 H1 results sometime in September. So get ready for 5 months of BS from FUM before reality hits. |
Posted at 15/4/2025 08:25 by kinwah MDI well done reading through to the end. The provision you picked up is due to FUM not calling off enough manufactured stock from its supplier due to poor demand. The extent of this contractual commitment is unknown but is a big worry. No wonder the auditors were shuffling in their seats. |
Posted at 15/4/2025 08:13 by kinwah The clues are there. The bulk of the sales come from 'retailer sell-in', i.e. stocking up on launch. Hence the interest in Eroxon Intense which would give FUM another chance of launch sales. The big non-mention in these results is repeat sales to consumers and we know that is because they are so poor. Most men who try it are dissatisfied with the outcome. FUM say targeting those men for whom it works is proving difficult especially as the 'wrong men' like older blokes try it out of interest only to be disappointed. Sadly I think FUM has to put itself up for sale before it runs out of cash. |
Posted at 19/3/2025 09:22 by glavey << LOST PET >>Missing since January 19th, 2025. If found, please return to ADVFN FUM board. |
Posted at 30/1/2025 11:36 by thebutler Can't understand why anybody would want to risk investing in AIM companies. They hardly ever pay a dividend, are run by incompetent overpaid directors, and usually go bust or de-list. It's best just sticking your money into high yielding FTSE shares like LGEN. |
Posted at 30/1/2025 11:01 by bandflex Amazon Euro and UK sales in last month, France 500, Spain 200, Italy 100, UK 100, Germany 50.If Amazon is a true reflection of sales then it seems to me that FUM are totally reliant on US sales for survival. |
Posted at 15/1/2025 07:58 by wheeze As trials go this is certainly a mickey mouse study. Clinical trials are expensive beasts and gobble large amounts of money. FUM dont need this study to bring their product to market- wonen can buy this off the shelf and many will use it for self indulgence. The word just needs to get out. |
Posted at 29/11/2024 17:31 by petroc Had the fraudster MDI reached out to investor relations at FUM regarding the big trade, he would have been told this:"Many thanks for reaching out. In regard to your query, this trade was an intra fund trade and requires no TR1 as there was no overall movement in the investors holding." |
Posted at 23/11/2024 13:26 by petroc Hi takeiteasy, can you tell bg23 that he should pop over to the LSE board if he wants to see proper chat about FUM? I don't apologise for helping 'destroy' this board, because I figured that's a better result than having a board where only one voice is heard. |
Posted at 04/9/2024 13:51 by mdi Marty as far as I am aware no direct blind efficacy comparison study against any similar placebo non medicated hydroalcoholic gel has ever been carried out. A study versus vicks couldn’t be blinded based on odour and perhaps consistency but others in the lubricant industry will understand why you referenced it and why they already sell and market lubricants and arousal gels with menthol. Which are also class 2a medical devices. Maybe some in the industry will now based on the ‘Eroxon’ ‘least burdensome’ medical device path seek to get them reclassified as class 2b and and also cleared as ‘clinically proven’ placebos that also have effects on men with psychological ED.And in reference to: ‘The discussion here is pointless FUM are retailing it, men are buying it’ Didn’t others previously highlight the same being said before about EPIC? Where is that product now? superg1 - 27 Jan 2014 - 07:23:44 - 9314 of 11722 Well it reads well re the launch in stores throughout the US and online. It will obvious who they have launched with once it's for sale, but I would imagine that will mean another rns when it launches anyway stating who it is. Interesting that Ansell will be promoting it individually and as a package. Green Web sold out in quick time so it will be interesting to see how well it goes on a full launch. superg1 - 21 Jan 2014 - 19:22:44 - 9300 of 11722 A post on iii today. Some will know what it is all about After contacting Green web the Amazon the retailers of PET500 I have been told that they "bought every available unit offered by the suppliers". They are keen to get more stock. I made no pretence as to my identity although avoided mentioning I was a FUM investor in my enquiries and simply asked why it was no longer being offered and why the online reviews were allocated. I was asked " Do you work for Ansell? We are extremely interested in continuing to carry the EPIC spray product." I believe the major U.S. retailers Amazon and others are competing to offer the product for the follow-on 'major' launch. I always try to manage my own expectations and therefore had assigned EPIC as a useful peripheral product in terms of driving revenues. I think there are signs that EPIC could turn out to be a more than 'useful' revenue generator for FUM. Looks like punters are desperate for the product, one on ebay apparently sold for $419 (from iii) hxxps://www.ebay.com loobrush - 13 May 2014 - 14:01:03 - 9696 of 11722 EPIC spray out of stock at AMAZON-is it all sold out? Weildy2 - 14 May 2014 - 17:47:44 - 9709 of 11722 OK Guys, here is my take on the FUM AGM yesterday. PET sales launched at 850 Walmart stores three weeks ago and should be available on line by the end of this week. Although it is far too soon to report sales figures, it has been selling in larger quantities than anticipated. Ansell are negotiating with other retailers. Will be sold through Walgreen (the US equivalent of Boots Chemist) which tOpgrader estimates to be approximately 870 stores. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions